Duke Cancer Institute — Durham, North Carolina

Duke Cancer Institute is a clinical research site located in Durham, North Carolina, United States 27705.

Crixeo Clinical Trials Trust Score: 33/100 (FAILING). This profile has not yet been claimed by the site owner.

Duke Cancer Institute has participated in 178 clinical trials with 74 currently active.

Therapeutic areas: Platinum-resistant Ovarian Cancer, Sarcoma, Myxoid/Round Cell Liposarcoma.

Sponsors: Genmab, Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Children's Oncology Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

Sponsor Feasibility Report

Trust Score: 33/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Institute?

Duke Cancer Institute has a Crixeo Trust Score of 33/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Institute conducted?

Duke Cancer Institute has 178 clinical trials on record, with 74 currently active. Their work covers Platinum-resistant Ovarian Cancer, Sarcoma, Myxoid/Round Cell Liposarcoma.

Is Duke Cancer Institute accredited by Crixeo Clinical Trials?

Duke Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.